Publication date: Jul 17, 2025
-Imagine having a protein design space and a chemistry design space fused together,” Cronin said. Kevin McGowan, Chemify’s chief business officer, said the company’s -15 to 18″ customers and commercial partners include -over a dozen” global biopharmas, none of which the company will disclose. By digitizing chemistry, Chemify aims to broaden access reliably, at scale, to chemical space-the set of all molecules that could possibly exist. We now bring programmable organic chemistry and together that opens up a new design space. ” -It could be as quick as the middle of next year, but it may be toward the end of next year, going into the year after. -90% there” -It seems that Chemify will have the technology to access the entire accessible drug chemical space by the end of this year, 2025. The company has also received a grant of lb1. 1 million (about $1. 5 million) from Scotland’s national economic development agency, Scottish Enterprise, toward the project.
| Concepts | Keywords |
|---|---|
| Biopharma | Chemical |
| Ceo | Chemifarm |
| Robotics | Chemify |
| Tuberculosis | Chemifys |
| Chemistry | |
| Company | |
| Cronin | |
| Design | |
| Drug | |
| Glasgow | |
| Molecules | |
| Said | |
| Space | |
| Year |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | IDO | facility |
| disease | IDO | production |
| disease | IDO | protein |
| disease | IDO | history |
| disease | IDO | site |
| drug | DRUGBANK | Cardiolipin |
| disease | MESH | cancer |
| disease | MESH | tuberculosis |
| pathway | KEGG | Tuberculosis |
| disease | MESH | malaria |
| pathway | KEGG | Malaria |